Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Apr;80(4):370–373. doi: 10.1136/adc.80.4.370

Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds

S Husain 1, Z Mughal 1, G Williams 1, K Ward 1, C Smith 1, J Dutton 1, W Fraser 1
PMCID: PMC1717887  PMID: 10086947

Abstract

Urinary pyridinoline and deoxypyridinoline, pyridinium crosslinks released during breakdown of mature collagen, might serve as useful markers of bone resorption. Before their role can be identified, reference values must be established. In this study, free pyridinoline (f-Pyr), free deoxypyridinoline (f-DPyr), and creatinine (Cr) were measured in first morning void urine samples from 250 girls and 265 boys between the ages of 4 and 10 years. Overall, there was a decrease in f-Pyr:Cr and f-DPyr:Cr ratios with increasing age in both sexes, but there was a wide range of values for individuals of similar ages. Further studies are required to assess whether urinary pyridinium crosslink excretion is sufficiently deranged in conditions affecting bone metabolism for the measurement of these compounds to be of clinical value.



Full Text

The Full Text of this article is available as a PDF (105.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbiati G., Bartucci F., Longoni A., Fincato G., Galimberti S., Rigoldi M., Castiglioni C. Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner. 1993 Apr;21(1):9–19. doi: 10.1016/s0169-6009(08)80116-x. [DOI] [PubMed] [Google Scholar]
  2. Açil Y., Brinckmann J., Notbohm H., Müller P. K., Bätge B. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). Scand J Clin Lab Invest. 1996 May;56(3):275–283. doi: 10.3109/00365519609088617. [DOI] [PubMed] [Google Scholar]
  3. Birkebaek N. H., Esberg G., Andersen K., Wolthers O., Hassager C. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child. 1995 Dec;73(6):524–527. doi: 10.1136/adc.73.6.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Black D., Duncan A., Robins S. P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem. 1988 Feb 15;169(1):197–203. doi: 10.1016/0003-2697(88)90274-6. [DOI] [PubMed] [Google Scholar]
  5. Bollen A. M., Eyre D. R. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone. 1994 Jan-Feb;15(1):31–34. doi: 10.1016/8756-3282(94)90888-5. [DOI] [PubMed] [Google Scholar]
  6. Delmas P. D., Schlemmer A., Gineyts E., Riis B., Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res. 1991 Jun;6(6):639–644. doi: 10.1002/jbmr.5650060615. [DOI] [PubMed] [Google Scholar]
  7. Doull I., Freezer N., Holgate S. Osteocalcin, growth, and inhaled corticosteroids: a prospective study. Arch Dis Child. 1996 Jun;74(6):497–501. doi: 10.1136/adc.74.6.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eastell R., Colwell A., Hampton L., Reeve J. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res. 1997 Jan;12(1):59–65. doi: 10.1359/jbmr.1997.12.1.59. [DOI] [PubMed] [Google Scholar]
  9. Eastell R., Simmons P. S., Colwell A., Assiri A. M., Burritt M. F., Russell R. G., Riggs B. L. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clin Sci (Lond) 1992 Sep;83(3):375–382. doi: 10.1042/cs0830375. [DOI] [PubMed] [Google Scholar]
  10. Freeman J. V., Cole T. J., Chinn S., Jones P. R., White E. M., Preece M. A. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):17–24. doi: 10.1136/adc.73.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fujimoto S., Kubo T., Tanaka H., Miura M., Seino Y. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab. 1995 Jun;80(6):1922–1928. doi: 10.1210/jcem.80.6.7775642. [DOI] [PubMed] [Google Scholar]
  12. MacDonald A. G., Birkinshaw G., Durham B., Bucknall R. C., Fraser W. D. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol. 1997 Jan;36(1):50–53. doi: 10.1093/rheumatology/36.1.50. [DOI] [PubMed] [Google Scholar]
  13. Marowska J., Kobylińska M., Lukaszkiewicz J., Tałajko A., Rymkiewicz-Kluczyńska B., Lorenc R. S. Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application. Bone. 1996 Dec;19(6):669–677. doi: 10.1016/s8756-3282(96)00284-0. [DOI] [PubMed] [Google Scholar]
  14. McLaren A. M., Isdale A. H., Whiting P. H., Bird H. A., Robins S. P. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheumatol. 1993 Apr;32(4):307–312. doi: 10.1093/rheumatology/32.4.307. [DOI] [PubMed] [Google Scholar]
  15. Pasquali M., Dembure P. P., Still M. J., Elsas L. J. Urinary pyridinium cross-links: a noninvasive diagnostic test for Ehlers-Danlos syndrome type VI. N Engl J Med. 1994 Jul 14;331(2):132–133. doi: 10.1056/NEJM199407143310217. [DOI] [PubMed] [Google Scholar]
  16. Pratt J. H., Manatunga A. K., Peacock M. A comparison of the urinary excretion of bone resorptive products in white and black children. J Lab Clin Med. 1996 Jan;127(1):67–70. doi: 10.1016/s0022-2143(96)90167-5. [DOI] [PubMed] [Google Scholar]
  17. Rauch F., Schönau E., Woitge H., Remer T., Seibel M. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol. 1994;102(2):94–97. doi: 10.1055/s-0029-1211269. [DOI] [PubMed] [Google Scholar]
  18. Robins S. P. Biochemical markers for assessing skeletal growth. Eur J Clin Nutr. 1994 Feb;48 (Suppl 1):S199–S209. [PubMed] [Google Scholar]
  19. Russell R. G. The assessment of bone metabolism in vivo using biochemical approaches. Horm Metab Res. 1997 Mar;29(3):138–144. doi: 10.1055/s-2007-979007. [DOI] [PubMed] [Google Scholar]
  20. Shaw N. J., Dutton J., Fraser W. D., Smith C. S. Urinary pyridinoline and deoxypyridinoline excretion in children. Clin Endocrinol (Oxf) 1995 Jun;42(6):607–612. doi: 10.1111/j.1365-2265.1995.tb02687.x. [DOI] [PubMed] [Google Scholar]
  21. Uebelhart D., Schlemmer A., Johansen J. S., Gineyts E., Christiansen C., Delmas P. D. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab. 1991 Feb;72(2):367–373. doi: 10.1210/jcem-72-2-367. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES